Emu Oil and protection from experimentally-induced ulcerative colitis and Crohn's disease

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1073340

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

The inflammatory bowel diseases (IBD), encompassing ulcerative colitis and Crohn’s disease, are chronic intestinal inflammatory disorders of unknown cause. Current treatments for IBD are variably effective highlighting the need for improved therapeutic approaches. Emu Oil is reported to exert potent anti-inflammatory and antioxidant effects. Using well established experimental models, we seek to determine the potential efficacy and underlying mechanism of Emu Oil action in acute and chronic IBD.

Funded Activity Details

Start Date: 01-01-2014

End Date: 01-01-2017

Funding Scheme: Early Career Fellowships

Funding Amount: $316,449.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Medical Physiology not elsewhere classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Crohn's disease | anti-inflammatory | complementary medicine | fatty acids | gastroenterology | gene expression | indigenous health | inflammatory bowel disease (IBD) | intestinal | ulcerative colitis

Related Links